Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, announced that it has signed an agreement with GlaxoSmithKline to acquire for...
Pernix Therapeutics Holdings, Inc. a specialty pharmaceutical company, announced that the FDA has approved Treximet (sumatriptan and naproxen sodium) for...
Pozen Inc. announced the acquisition of Tribute Pharmaceuticals Canada Inc., a Canadian specialty pharmaceutical company, in a transaction valued at...